← Back to headlines
AstraZeneca Stock Jumps After Surprise Trial Win for COPD Drug
AstraZeneca's experimental drug for chronic obstructive pulmonary disease (COPD) has shown successful outcomes in two Phase 3 clinical trials, leading to a 4% jump in the company's stock.
27 Mar, 11:39 — 27 Mar, 12:54
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
cnbc
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
cnbcMostly Factual3h ago
AstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failed
The experimental drug reduced flare-ups for patients with chronic obstructive pulmonary disease, Astra said Friday.
Read full article →seeking-alphaMixed4h ago
AstraZeneca succeeds in two Phase 3 trials for COPD therapy
Read full article →Coverage Timeline
First report: seeking-alpha · 27 Mar, 11:39|Full coverage: 2 · 1h|Window: 1h
Left-leaningCenterRight-leaning
